Funding for this research was provided by:
National Institute on Drug Abuse (K23DA039769)
Article History
Accepted: 17 July 2021
First Online: 26 July 2021
Declarations
:
: Dr. Nicole Ennis, Dr. Seyram Butame, and Ms. Hemali Joshi do not have any conflict of interest to report. Dr. Laura Armas served on advisory boards for ViiV Healthcare and as a consultant for Gilead Sciences.
: IRB approval for this study was obtained via Florida State University Institutional Review Board.
: Consent to participate appropriate consent to use the de-identified EHR data in this manuscript was obtained.
: N/A, no individual’s data or image included.